2022 Annual Meeting | N6 - Neuroscience in the Clinic: Neurological Implications of Long-haul COVID Infection

Date Thursday 04/07/22

Time 01:00 PM - 03:00 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Neuroscience in the Clinic Session

Director(s) Riley Bove, MD, FAAN, Kiran Thakur, MD, FAAN

Topic(s) Infectious Disease

Learning Objectives To develop knowledge on post SARS-CoV-2 neurological and psychiatric symptoms and conditions.
To understand the proposed pathogenic mechanisms of post-SARS-CoV-2 neurological manifestations.
To develop an understanding of novel methods including biomarker studies to evaluate post-SARS-CoV2 effects.
To educate clinicians on the spectrum of neurological manifestations associated with long COVID-19, and the possible treatment modalities.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Advanced

Program Tracks COVID-19

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Didactic

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:15 PM PDT	Speaker	Introduction and Case Presentation
01:00 PM - 01:00 PM PDT	Speaker	Walk-in Slides Riley Bove, MD, FAAN
01:15 PM - 01:45 PM PDT	Speaker	Clinical Evaluation of Post SARS-CoV-2 Neurological Symptoms: Assessment and Management Joanna Hellmuth, MD
01:45 PM - 01:50 PM PDT	Speaker	Questions Joanna Hellmuth, MD
01:50 PM - 02:00 PM PDT	Abstract	001 - Mid and Long-term Neurological and Neuropsychiatric Manifestations of Post-COVID-19 Syndrome: A Meta-analysis Lavienraj Premraj
02:00 PM - 02:05 PM PDT	Speaker	Questions: Abstract Presentation
02:05 PM - 02:35 PM PDT	Speaker	Scientific Mechanisms of Post-SARS-CoV-2 Neurological Manifestations Avindra Nath, MD, MBBS, FAAN
02:35 PM - 02:45 PM PDT	Abstract	002 - Cognitive Symptoms After Mild SARS-CoV-2 Infection Associate with Higher Levels of CSF Immune Activation and Immunovascular Markers Joanna Hellmuth, MD
02:45 PM - 03:00 PM PDT	Speaker	Question and Answer: Panel Discussion and Case Summary Riley Bove, MD, FAAN

Faculty Disclosures
Bruce L. Miller, MD, FAAN	Dr. Miller has nothing to disclose.
Avindra Nath, MD, MBBS, FAAN	The institution of Dr. Nath has received research support from National Institutes of Health. The institution of Dr. Nath has received research support from Target ALS. Dr. Nath has received intellectual property interests from a discovery or technology relating to health care.
Samuel Pleasure, MD, PhD	Dr. Pleasure has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. The institution of Dr. Pleasure has received research support from NINDS, NIMH, NIDA, National MS Society, Brain Research Foundation, John Merck Fund, Whitehall Foundation, Lupus Research Association, Juvenile Diabetes Research Foundation.
Joanna Hellmuth, MD	Dr. Hellmuth has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for McAngus Goudelock & Courie law firm.
Kiran Thakur, MD, FAAN	Dr. Thakur has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Delve Bio. The institution of Dr. Thakur has received research support from Center for Disease Control and Prevention.
Riley Bove, MD, FAAN	Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NeurologyLive. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Bove has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jansen. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadenza. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Bove has received research support from Biogen. The institution of Dr. Bove has received research support from Roche Genentech. The institution of Dr. Bove has received research support from Novartis. The institution of Dr. Bove has received research support from Eli Lilly.
Fanny M. Elahi, MD, PhD	Dr. Elahi has nothing to disclose.
	No disclosure on file
Breton Asken	Breton Asken has nothing to disclose.
Melanie Stephens, PhD	Dr. Stephens has nothing to disclose.
Jonathon Fanning, MBBS, PhD	Dr. Fanning has nothing to disclose.
Lavienraj Premraj	Mr. Premraj has nothing to disclose.
Sung-Min Cho	No disclosure on file

��ɫ��

��ɫ��